While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de...
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Sotera Healt...
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Sotera Health’s first quarter saw year-on-year revenue growth driven by strong performance in Sterigenics and Nordion, with the latter benefiting from favora...
Healthcare services company Sotera Health (NASDAQ:) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 10% year on year to ...
Healthcare services company Sotera Health (NASDAQ:) will be reporting earnings this Tuesday before market open. Here’s what investors should know. Sotera Hea...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged...
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Although the S&P 500 is down 2.1% over the past six months, Sotera Health Company’s stock price has fallen further to $14.85, losing shareholders 7.2% of the...
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how research tools & ...
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Sotera Health Company (NASDAQ:SHC) a...
The United States Department of Agriculture (USDA) has officially greenlit a massive $100 million initiative dubbed the "Screwworm Challenge," aimed at neutralizing a resurgent biological threat that hasn't plagued the American mainland in over half a century. As of March 2, 2026, federal authorities and state governments, led by Texas,
